Lists of common clinical trial management mistakes tend to read as a grab bag: a weak recruitment plan here, a missed deadline there, a stakeholder who felt left out of a decision. Treated as separate problems, each one gets its own separate fix, and the list never gets shorter. Looked at closely, most of them share a single root cause: nobody defined, in advance, who owns a given piece of the work and what process it has to follow. Fix that, and a surprising number of the “common mistakes” stop happening on their own.
Why the Symptoms Look Different but the Cause Doesn’t
A clinical trial runs through a wide set of stakeholders and committees, executive oversight boards, data safety monitoring boards, steering committees, advisory boards, each with its own charter and its own expectations of the study team. When roles and processes are clear, disagreements among that group are normal and get resolved through the process built for that purpose. When they are not clear, the same disagreements surface as something else: a decision nobody remembers signing off on, a document version two committees are reviewing independently, a status update that takes a full meeting to produce because no other view of it exists.
None of those symptoms look, on the surface, like a governance problem. They look like a communication problem, or a tooling problem, or a people problem. Most of the time, they are downstream of the same thing: a piece of work with no clearly assigned owner and no defined process, left to whoever happens to notice it needs doing.
That misdiagnosis matters because it sends the fix in the wrong direction. A team that reads a missed handoff as a communication problem responds by asking people to communicate more, another meeting, another status email chain, which adds coordination overhead without addressing why the handoff was ambiguous in the first place. A team that reads the same failure as an ownership gap responds by assigning the handoff to a specific role with a defined process, which tends to make the problem stop recurring rather than just easier to talk about.
Where the Gap Actually Lives
Study teams are generally good at planning the parts of a trial that have an obvious owner from day one: the protocol, the statistical analysis plan, the safety monitoring charter. The gap tends to open in the space between those plans, the coordination work that connects one committee’s decision to another committee’s action, or one document’s current version to every site that is supposed to be working from it.
That space is where informal process takes over by default, because nobody assigned it formally. Whoever is most available, or most persistent, ends up owning it that week, and the process they use is whatever gets the immediate task done rather than a standard anyone could repeat. It works, most of the time, until the trial hits a period of real pressure and the informal version of the process turns out not to hold up.
The trouble is that this kind of gap is genuinely hard to see from the outside while things are going smoothly. A study team under no particular pressure can absorb a fair amount of informal coordination without any visible cost, which is exactly why the gap tends to persist unaddressed. It only becomes obvious once a deadline compresses, a committee membership changes mid-study, or an inspector asks a question the informal process was never built to answer.
Fixing the Cause Instead of the Symptom
Addressing this does not mean adding another layer of documentation on top of the plans a study already has. It means being explicit about ownership and process for the coordination work that sits between those plans, the same way the trial is already explicit about ownership of the protocol itself.
- Name an owner for every recurring decision, not just the plan that describes how the decision should be made, so “who handles this” has one answer instead of whoever is available.
- Define the review and sign-off sequence in advance, so a protocol amendment or a committee vote follows the same steps every time rather than being improvised under whatever deadline is closest.
- Keep one current version of record, visible to everyone who needs it, so different committees are never reviewing different drafts of the same document without realizing it.
- Make status visible without a status meeting, so an answer to “where does this stand” does not require pulling people off their actual work to produce it.
What Changes When Ownership Is Explicit
None of this replaces good clinical judgment, and it will not turn a genuinely difficult scientific or operational decision into an easy one. What it removes is the separate layer of risk that comes from good decisions getting lost, delayed, or contradicted because nobody owned the process around them. A governed execution environment exists to carry exactly that layer: standardized ownership and process for the coordination work between committees, with the documented trail that shows it happened the way it was supposed to.
The individual mistakes on any list will keep recurring as long as the underlying gap in ownership and process stays open. Close that gap once, at the structural level, and most of what looks like a long list of separate problems turns out to have been one problem the whole time. That is a more durable fix than working through the list item by item, and it is the kind of standardization sponsors get the most value from putting in place before pressure exposes where it is missing, not after.